SOX2 and neoplasm: We examined SOX2 expression by IHC of paraffin-embedded tumor tissues from 44 CRC patients and found that ∼20% of patients (9/44) stained strongly with the SOX2 antibody (Figure 6A, B, C, D, E, F).